Exosome facials: promising research, unanswered safety questions

What happened

Exosomes are tiny packages released by cells that can carry messages and other material. Some clinics apply products described as containing them during a facial or after microneedling, a procedure that makes tiny punctures in the skin. One Florida clinic markets this combination for skin repair and lists a face-and-neck treatment at $750. Those marketing claims are not proof that the exosomes work. (arsenaultaesthetics.com)

Researchers are testing related approaches in people. In a 2026 study, 75 people with facial surgery scars were randomly assigned to receive laser treatment alone or with a human- or plant-derived exosome product. Each person had five sessions. The groups given an exosome product showed some additional short-term improvements in scar appearance and skin measures. No serious side effects were reported. (pubmed.ncbi.nlm.nih.gov)

That study focused on scars and combined the products with a laser. It cannot tell us what an ordinary exosome facial does on its own.

Why it matters

A separate review of 16 human studies involving 503 people found that most reported improvements in at least one measure, such as wrinkles or skin hydration. But the studies used different treatments and measurements, and the reviewers rated their overall certainty as low or very low. Short follow-up also makes it hard to judge lasting results or uncommon harms. (pubmed.ncbi.nlm.nih.gov)

The FDA says there are currently no FDA-approved exosome products. Whether a particular cosmetic product requires approval depends on how it is used and marketed; a clinic’s use of an approved device does not itself establish approval of an accompanying exosome product. (fda.gov)

What we don't know

We do not know which preparation, if any, reliably improves aging skin, how long an effect might last, or the full long-term risks. Products and delivery methods differ. A review noted temporary redness and discomfort in studies, and a report of lasting lumps and scars after injections of a poorly defined product. That injection report should not be assumed to describe the risk of every product applied to the skin. (pmc.ncbi.nlm.nih.gov)

Sources and conflicts

This report draws on the human trial, a research review and FDA guidance. The trial abstract identifies hospital research funding; it does not provide enough information here to assess all author conflicts. The clinics cited sell the treatments they describe, so their benefit claims should be read as marketing.